|
COPS4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
5.41260369857355E-11 |
| Normal-vs-Stage3 |
3.12659897971912E-11 |
| Normal-vs-Stage4 |
3.17549997408406E-09 |
| Stage1-vs-Stage2 |
7.884800E-01 |
| Stage1-vs-Stage3 |
7.587400E-01 |
| Stage1-vs-Stage4 |
7.541200E-01 |
| Stage2-vs-Stage3 |
6.196200E-01 |
| Stage2-vs-Stage4 |
5.890800E-01 |
| Stage3-vs-Stage4 |
9.118000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
6.61692922676593E-14 |
| Normal-vs-Asian |
1.924130E-02 |
| Caucasian-vs-AfricanAmerican |
1.710760E-01 |
| Caucasian-vs-Asian |
9.570400E-01 |
| AfricanAmerican-vs-Asian |
6.232000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.01749728034883E-12 |
| Male-vs-Female |
3.962300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.59903210064749E-13 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
2.1094237467878E-15 |
| Normal-vs-Extreme_Obese |
3.179200E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.241400E-01 |
| Normal_Weight-vs-Obese |
5.876200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.321000E-01 |
| Extreme_Weight-vs-Obese |
1.602350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.760200E-01 |
| Obese-vs-Extreme_Obese |
4.744800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.01760000426054E-09 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.29059984921298E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.648800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.174600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.395800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.712200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.045400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.710000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.63014046705712E-12 |
| Normal-VS-KIRP CIMP |
5.59619994788818E-09 |
| Normal-VS-Unclassified PRCC |
3.5456082514429E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.235020E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.688000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.122600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.902000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.344600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.830200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66533453693773E-15 |
| Normal-vs-N1 |
1.03249631067115E-11 |
| Normal-vs-N2 |
6.5649000002832E-07 |
| N0-vs-N1 |
7.893800E-01 |
| N0-vs-N2 |
5.476000E-01 |
| N1-vs-N2 |
4.763600E-01 |
|
|
